Correlative Analyses of Patient and Clinical Characteristics Associated with Efficacy in Tisagenlecleucel-Treated Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients in the Juliet Trial

被引：26

作者：

Westin, Jason R. ^{[1
]}

Tam, Constantine S. ^{[2
,3
]}

Borchmann, Peter ^{[4
]}

Jaeger, Ulrich ^{[5
]}

McGuirk, Joseph P. ^{[6
]}

Holte, Harald ^{[7
]}

Waller, Edmund K. ^{[8
]}

Jaglowski, Samantha ^{[9
]}

Bishop, Michael R. ^{[10
]}

Andreadis, Charalambos ^{[11
]}

Foley, Stephen Ronan ^{[12
]}

Fleury, Isabelle ^{[13
]}

Ho, P. Joy ^{[14
]}

Mielke, Stephan ^{[15
]}

Teshima, Takanori ^{[16
]}

Schuster, Stephen J. ^{[17
]}

Bachanova, Veronika ^{[18
]}

Maziarz, Richard T. ^{[19
]}

Van Besien, Koen ^{[20
]}

Izutsu, Koji ^{[21
]}

Kersten, Marie Jose ^{[22
]}

Magenau, John M. ^{[23
]}

Wagner-Johnston, Nina D. ^{[24
,25
]}

Kato, Koji ^{[26
]}

Corradini, Paolo ^{[27
]}

Han, Xia ^{[28
]}

Tiwari, Ranjan ^{[29
]}

Agoulnik, Sergei ^{[30
]}

Eldjerou, Lamis K. ^{[28
]}

Pacaud, Lida Bubuteishvili ^{[28
]}

Salles, Gilles A. ^{[31
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA

[2] St Vincents Hosp, Melbourne, Vic, Australia

[3] Univ Melbourne, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[4] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany

[5] Med Univ Vienna, Dept Med 1, Clin Div Hematol & Hemostaseol, Vienna Gen Hosp, Vienna, Austria

[6] Univ Kansas Hlth Syst, Dept Internal Med, Kansas City, KS USA

[7] Oslo Univ Hosp, Dept Oncol, Oslo, Norway

[8] Emory Clin, Div Hematol Oncol, Atlanta, GA 30322 USA

[9] Ohio State Univ, James Comprehens Canc Ctr, Columbus, OH 43210 USA

[10] Univ Chicago, Dept Med, Hematol Oncol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA

[11] Univ Calif San Francisco, Dept Med, Helen Diller Family Comp, San Francisco, CA 94143 USA

[12] McMaster Univ, Hamilton, ON, Canada

[13] Univ Paris Diderot, Montreal, PQ, Canada

[14] Royal Prince Alfred Hosp, Inst Haematol, Dept Haematol, Camperdown, NSW, Australia

[15] Univ Hosp Wurzburg, Wurzburg, Germany

[16] Hokkaido Univ Hosp, Dept Hematol, Sapporo, Hokkaido, Japan

[17] Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USA

[18] Univ Minnesota, Div Hematol Oncol & Transplantat, Minneapolis, MN USA

[19] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[20] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY USA

[21] Natl Canc Ctr, Dept Hematol, Tokyo, Japan

[22] Acad Med Ctr, Dept Hematol, Amsterdam, Netherlands

[23] Univ Michigan, Ann Arbor, MI 48109 USA

[24] Johns Hopkins Sch Med, Baltimore, MD USA

[25] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[26] Kyushu Univ Hosp, Dept Med & Biosyst Sci, Fukuoka, Japan

[27] Univ Milan, Fdn IRCCS Ist Nazl Tumori, Milan, Italy

[28] Novartis Pharmaceut, E Hanover, NJ USA

[29] Novartis Healthcare Pvt Ltd, Hyderabad, Telangana, India

[30] Novartis Inst Biomed Res, Cambridge, MA USA

[31] Lyon Sud Hosp, Hosp Civils Lyon, Dept Hematol, Pierre Benite, France

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-129107

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4103

引用

页数：6

共 50 条

[1] Correlative Analyses of Patient and Clinical Characteristics Associated with Efficacy iN Tisagenlecleucel-Treated Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients in the Juliet Trial
Westin, Jason
Tam, Constantine
Borchmann, Peter
Jaeger, Ulrich
McGuirk, Joseph
Holte, Harald
Waller, Edmund
Jaglowski, Samantha
Bishop, Michael
Andreadis, Charalambos
Foley, Stephen Ronan
Fleury, Isabelle
Ho, P. Joy
Mielke, Stephan
Teshima, Takanori
Schuster, Stephen
Bachanova, Veronika
Maziarz, Richard
Van Besien, Koen
Izutsu, Koji
Kersten, Marie Jose
Magenau, John
Wagner-Johnston, Nina
Kato, Koji
Corradini, Paolo
Han, Xia
Tiwari, Ranjan
Agoulnik, Sergei
Elderjou, Lamis
Pacaud, Lida Bubuteishvili
Salles, Gilles
BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 48 - 51
[2] Correlative analyses of patient and clinical characteristics associated with efficacy in tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma patients in the JULIET trial
Westin, J.
Tam, C. S.
Borchmann, P.
Jaeger, U.
McGuirk, J. P.
Holte, H.
Waller, E. K.
Jaglowski, S.
Bishop, M. R.
Andreadis, C.
Foley, S. R.
Fleury, I
Ho, P. J.
Mielke, S.
Teshima, T.
Schuster, S. J.
Bachanova, V
Maziarz, R. T.
Besien, K., V
Izutsu, K.
Kersten, M. J.
Wagner-Johnston, N. D.
Kato, K.
Corradini, P.
Han, X.
Tiwari, R.
Eldjerou, L. K.
Pacaud, L. B.
Salles, G. A.
ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 58 - 58
[3] Correlative Analyses of Cytokine Release Syndrome and Neurological Events in Tisagenlecleucel-Treated Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients
Bachanova, Veronika
Westin, Jason
Tam, Constantine
Borchmann, Peter
Jaeger, Ulrich
McGuirk, Joseph
Holte, Harald
Waller, Edmund
Jaglowski, Samantha
Bishop, Michael
Andreadis, Charalambos
Foley, Ronan S.
Fleury, Isabelle
Teshima, Takanori
Mielke, Stephan
Salles, Gilles
Ho, P. Joy
Izutsu, Koji
Maziarz, Richard
Van Besien, Koen
Kersten, Marie Jose
Wagner-Johnston, Nina
Kato, Koji
Corradini, Paolo
Han, Xia
Agoulnik, Sergei
Chu, Jufen
Eldjerou, Lamis
Pacaud, Lida
Schuster, Stephen
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S251 - S252
[4] Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma
Jaeger, Ulrich
Tam, Constantine S.
Borchmann, Peter
McGuirk, Joseph P.
Johansen, Marianne
Waller, Edmund K.
Jaglowski, Samantha
Andreadis, Charalambos
Foley, Stephen R.
Westin, Jason R.
Fleury, Isabelle
Ho, P. Joy
Mielke, Stephan
Teshima, Takanori
Salles, Gilles
Schuster, Stephen J.
He, Fiona
Maziarz, Richard T.
Mayer, Sebastian
Makita, Shinichi
Kersten, Marie J.
Ghosh, Monalisa
Wagner-Johnston, Nina
Kato, Koji
Corradini, Paolo
Goto, Hideki
Colicino, Silvia
Agarwal, Abhijit
Lobetti-Bodoni, Chiara
Bishop, Michael R.
BLOOD ADVANCES, 2022, 6 (16) : 4816 - 4820
[5] Sustained disease control and correlative analyses in tisagenlecleucel treated relapsed/refractory diffuse large B-Cell lymphoma patients (r/r DLBCL)
Borchmann, P.
Bachanova, V.
Westin, J.
Tam, C.
Jaeger, U.
McGuirk, J.
Holte, H.
Waller, E.
Jaglowski, S.
Bishop, M.
Andreadis, C.
Foley, S. R.
Fleury, I.
Teshima, T.
Mielke, S.
Salles, G.
Ho, J.
Izutsu, K.
Maziarz, R.
van Besein, K.
Kersten, M. J.
Wagner-Johnston, N.
Kato, K.
Corradini, P.
Han, X.
Agoulnik, S.
Chu, J.
Eldjerou, L.
Pacaud, L.
Schuster, S.
ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 238 - 238
[6] Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Schuster, Stephen J.
Bishop, Michael R.
Tam, Constantine S.
Waller, Edmund K.
Borchmann, Peter
McGuirk, Joseph P.
Jaeger, Ulrich
Jaglowski, Samantha
Andreadis, Charalambos
Westin, Jason R.
Fleury, Isabelle
Bachanova, Veronika
Foley, S. Ronan
Ho, P. Joy p
Mielke, Stephan
Magenau, John M.
Holte, Harald
Pantano, Serafino
Pacaud, Lida B.
Awasthi, Rakesh
Chu, Jufen
Anak, Ozlem
Salles, Gilles
Maziarz, Richard T.
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (01): : 45 - 56
[7] Tisagenlecleucel and Lisocabtagene Maraleucel: Comparative Efficacy in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Schuster, Stephen J.
Zhang, Jie
Yang, Hongbo
Agarwal, Abhijit
Tang, Wenxi
Prieto, Marcela Martinez
Bollu, Vamsi
Kuzan, David
Maziarz, Richard
Kersten, Marie Jose
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S380 - S381
[8] Efficacy and safety of tisagenlecleucel in Japanese adult patients with relapsed/refractory diffuse large B-cell lymphoma
Hideki Goto
Shinichi Makita
Koji Kato
Kota Tokushige
Taizo Fujita
Koichi Akashi
Koji Izutsu
Takanori Teshima
International Journal of Clinical Oncology, 2020, 25 : 1736 - 1743
[9] Efficacy and safety of tisagenlecleucel in Japanese adult patients with relapsed/refractory diffuse large B-cell lymphoma
Goto, Hideki
Makita, Shinichi
Kato, Koji
Tokushige, Kota
Fujita, Taizo
Akashi, Koichi
Izutsu, Koji
Teshima, Takanori
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (09) : 1736 - 1743
[10] Correlation of Bridging and Lymphodepleting Chemotherapy with Clinical Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with Tisagenlecleucel
Andreadis, Charalambos
Tam, Constantine S.
Borchmann, Peter
Jaeger, Ulrich
McGuirk, Joseph P.
Holte, Harald
Waller, Edmund K.
Jaglowski, Samantha
Bishop, Michael R.
Foley, Stephen Ronan
Westin, Jason R.
Fleury, Isabelle
Ho, P. Joy
Mielke, Stephan
Teshima, Takanori
Salles, Gilles A.
Schuster, Stephen J.
Bachanova, Veronika
Maziarz, Richard T.
Van Besien, Koen
Izutsu, Koji
Magenau, John M.
Wagner-Johnston, Nina D.
Kato, Koji
Corradini, Paolo
Tiwari, Ranjan
Awasthi, Rakesh
Lawniczek, Tomasz
Eldjerou, Lamis K.
Kersten, Marie Jose
BLOOD, 2019, 134

← 1 2 3 4 5 →